Literature DB >> 22064970

The vitamin D receptor regulates rheumatoid arthritis synovial fibroblast invasion and morphology.

Teresina Laragione1, Anish Shah, Pércio S Gulko.   

Abstract

Serum levels of vitamin D levels are commonly reduced in patients with rheumatoid arthritis (RA) and have been implicated in disease pathogenesis. We recently identified a new vitamin D receptor transcriptional signature in synovial tissues from rats with mild and nonerosive arthritis, suggesting a vitamin D-mediated protective effect. In the present study, we address the hypothesis that part of the vitamin D protective effect is mediated via interference with fibroblast-like synoviocyte (FLS) invasive properties, an in vitro cellular phenotype that correlates with radiographic and histological damage in pristane-induced arthritis and RA. FLSs derived from DA rats with pristane-induced arthritis and RA patients were studied in an in vitro model of invasion through a collagen-rich barrier (Matrigel) over a 24-h period, in the presence or absence of calcitriol, an active form of vitamin D. Matrix metalloprotease (MMP) expression levels were analyzed with zymography and quantitative real-time polymerase chain reaction, and the cytoskeleton was studied with immunofluorescense microscopy. Calcitriol significantly inhibited DA and RA FLS invasion by 54% and 53%, respectively. Calcitriol also reduced interleukin (IL)-1β-induced expression of MMP-1 by 95% in DA FLSs and by 73.5% in RA FLS. Calcitriol treatment reduced actin cytoskeleton reorganization, reduced polarized formation of lamellipodia and reduced colocalization of phosphorylated focal adhesion kinase (p-FAK) with lamellipodia, all consistent with reduced cell ability to move and invade. In conclusion, we identified a new effect of calcitriol in FLS invasion. This discovery suggests that the reduced serum levels of vitamin D and its metabolites commonly seen in RA might increase risk for FLS-mediated cartilage and bone invasion and erosions. Treatment with vitamin D or its analogs has the potential to become a helpful adjuvant aimed at preventing or reducing joint destruction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22064970      PMCID: PMC3320133          DOI: 10.2119/molmed.2011.00410

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  40 in total

Review 1.  The genetics revolution and the assault on rheumatoid arthritis.

Authors:  M F Seldin; C I Amos; R Ward; P K Gregersen
Journal:  Arthritis Rheum       Date:  1999-06

2.  Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.

Authors:  Erik J Tokar; Mukta M Webber
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Efficacy and mechanisms of action of vitamin D in experimental polyarthritis.

Authors:  Mahin Moghaddami; Graham Mayrhofer; Paul H Anderson; Howard A Morris; Mark Van Der Hoek; Leslie G Cleland
Journal:  Immunol Cell Biol       Date:  2011-03-29       Impact factor: 5.126

4.  Autocrine control of vitamin D metabolism in synovial cells from arthritic patients.

Authors:  S J Smith; M E Hayes; P L Selby; E B Mawer
Journal:  Ann Rheum Dis       Date:  1999-06       Impact factor: 19.103

5.  1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis.

Authors:  M T Cantorna; C E Hayes; H F DeLuca
Journal:  J Nutr       Date:  1998-01       Impact factor: 4.798

6.  Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts.

Authors:  Frances L Szeto; Jun Sun; Juan Kong; Yingli Duan; Anne Liao; James L Madara; Yan Chun Li
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12-23       Impact factor: 4.292

7.  Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis.

Authors:  Tanja C A Tolboom; Annette H M van der Helm-Van Mil; Rob G H H Nelissen; Ferdinand C Breedveld; René E M Toes; Tom W J Huizinga
Journal:  Arthritis Rheum       Date:  2005-07

8.  QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells.

Authors:  Sujatha Sundaram; Matthew J Beckman; Amandeep Bajwa; Jeffrey Wei; Kathleen M Smith; Gary H Posner; David A Gewirtz
Journal:  Mol Cancer Ther       Date:  2006-11       Impact factor: 6.261

9.  Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time.

Authors:  K W Drossaers-Bakker; M de Buck; D van Zeben; A H Zwinderman; F C Breedveld; J M Hazes
Journal:  Arthritis Rheum       Date:  1999-09

10.  The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage.

Authors:  Max Brenner; Hsiang-Chi Meng; Nuriza C Yarlett; Marie M Griffiths; Elaine F Remmers; Ronald L Wilder; Pércio S Gulko
Journal:  Arthritis Rheum       Date:  2005-01
View more
  18 in total

Review 1.  Vitamin D in rheumatoid arthritis-towards clinical application.

Authors:  Louisa E Jeffery; Karim Raza; Martin Hewison
Journal:  Nat Rev Rheumatol       Date:  2015-10-13       Impact factor: 20.543

Review 2.  Vitamin D Deficiency and Rheumatoid Arthritis.

Authors:  Larissa Lumi Watanabe Ishikawa; Priscila Maria Colavite; Thais Fernanda de Campos Fraga-Silva; Luiza Ayumi Nishiyama Mimura; Thais Graziela Donegá França; Sofia Fernanda Gonçalves Zorzella-Pezavento; Fernanda Chiuso-Minicucci; Larissa Doddi Marcolino; Marcimara Penitenti; Maura Rosane Valerio Ikoma; Alexandrina Sartori
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 3.  Vitamin D in systemic and organ-specific autoimmune diseases.

Authors:  Nancy Agmon-Levin; Emanuel Theodor; Ramit Maoz Segal; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

4.  Vitamin D receptor polymorphisms and expression profile in rheumatoid arthritis Brazilian patients.

Authors:  Catarina Addobbati Jordão Cavalcanti; Jaqueline de Azevêdo Silva; Will de Barros Pita; Tiago Degani Veit; Odirlei Andre Monticielo; Ricardo Machado Xavier; João Carlos Tavares Brenol; Cleiton Viegas Brenol; Thiago Sotero Fragoso; Alexandre Domingues Barbosa; Ângela Luiza Branco Pinto Duarte; Renê Donizeti Ribeiro Oliveira; Paulo Louzada-Júnior; Eduardo Antônio Donadi; Sergio Crovella; José Artur Bogo Chies; Paula Sandrin-Garcia
Journal:  Mol Biol Rep       Date:  2015-12-19       Impact factor: 2.316

5.  Analyses of synovial tissues from arthritic and protected congenic rat strains reveal a new core set of genes associated with disease severity.

Authors:  Max Brenner; Teresina Laragione; Pércio S Gulko
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

6.  The status of serum vitamin D in patients attending a general rheumatology clinic in the UK.

Authors:  Malack Alachkar; Yee Ping Teoh; Margaret M O'Sullivan
Journal:  Clin Rheumatol       Date:  2013-06-05       Impact factor: 2.980

Review 7.  Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of Supplementation.

Authors:  Jason R Goldsmith
Journal:  Healthcare (Basel)       Date:  2015-04-14

Review 8.  Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.

Authors:  Wendy Dankers; Edgar M Colin; Jan Piet van Hamburg; Erik Lubberts
Journal:  Front Immunol       Date:  2017-01-20       Impact factor: 7.561

9.  Enrichment of vitamin D response elements in RA-associated loci supports a role for vitamin D in the pathogenesis of RA.

Authors:  A Yarwood; P Martin; J Bowes; M Lunt; J Worthington; A Barton; S Eyre
Journal:  Genes Immun       Date:  2013-05-02       Impact factor: 2.676

10.  Cardiotrophin-1 induces matrix metalloproteinase-1 in human aortic endothelial cells.

Authors:  Akinori Tokito; Michihisa Jougasaki; Tomoko Ichiki; Shuichi Hamasaki
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.